Baxter to Present at 42nd Annual J.P. Morgan Healthcare Conference
Get Alerts BAX Hot Sheet
Join SI Premium – FREE
DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE: BAX), a global medtech leader, will present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024. José (Joe) E. Almeida, Baxter’s chairman, president and chief executive officer, is scheduled to present at 10:30 a.m. Pacific Time.
The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through Friday, July 5, 2024.
About Baxter
Every day, millions of patients and caregivers rely on Baxter’s leading portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. For more than 90 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen. With products, digital health solutions and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on X/Twitter, LinkedIn and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231213876672/en/
Media Contact
Steve Brett, (224) 948-5353
[email protected]
Investor Contact
Clare Trachtman, (224) 948-3020
Source: Baxter International Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Halliburton Announces Dividend
- Bitcoin Price Prediction: BTC Eyes $100K Comeback as AlphaPepe Buyers Countdown to the 4th CEX Reveal
- The Games DEA Attorneys Play: What Marijuana Rescheduling Closing Brief Didn't Tell Judge Julius
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
JPMorgan, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share